Superior Planning, LLC’s Cogent Biosciences COGT Stock Holding History

Superior Planning, LLC’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$608	Buy	+19	New	+$702	﹤0.01%	1852

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return

Superior Planning, LLC's COGT Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Cogent Biosciences (COGT) in Q3 2026: 19 shares worth $608. The stake represents ﹤0.01% of the portfolio and ranks #1852 among its holdings.

149 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

Superior Planning, LLC held 19 shares of Cogent Biosciences worth $608 as of Q3 2026.
Cogent Biosciences was a new Superior Planning, LLC position in Q3 2026.
Cogent Biosciences made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1852 holding.
149 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.